Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

RadNet, Inc. - Common Stock (NQ:RDNT)

79.72 +1.28 (+1.63%)
Streaming Delayed Price Updated: 9:39 AM EDT, Oct 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about RadNet, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
US Stock Likely To Open Lower As US-China Tariff War Continues: 'Valuations Are Now Looking More Compelling,' Says Expert
U.S. stock futures declined on Wednesday following a muted day of trading on Tuesday. Futures of indices were lower in premarket. 
Via Benzinga
Where RadNet Stands With Analysts
 
Via Benzinga
Reflecting On Testing & Diagnostics Services Stocks’ Q4 Earnings: Guardant Health (NASDAQ:GH)
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how testing & diagnostics services stocks fared in Q4, starting... 
Via StockStory
Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking NeoGenomics (NASDAQ:NEO)
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the testing & diagnostics services stocks, including NeoGenomics (NASDAQ:NEO) and its peers. 
Via StockStory
Forecasting The Future: 4 Analyst Projections For RadNet
 
Via Benzinga
Earnings Scheduled For February 27, 2025
 
Via Benzinga
Breaking Down RadNet: 5 Analysts Share Their Views
 
Via Benzinga
Q4 Earnings Outperformers: AMN Healthcare Services (NYSE:AMN) And The Rest Of The Healthcare Providers & Services Stocks
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare providers & services industry, including AMN Healthcare Services... 
Via StockStory
A Look Back at Testing & Diagnostics Services Stocks’ Q4 Earnings: Labcorp (NYSE:LH) Vs The Rest Of The Pack
Looking back on testing & diagnostics services stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Labcorp (NYSE:LH) and its peers. 
Via StockStory
RadNet (RDNT): Buy, Sell, or Hold Post Q4 Earnings?
RadNet has gotten torched over the last six months - since September 2024, its stock price has dropped 25.7% to $51.34 per share. This may have investors wondering how to approach the situation. 
Via StockStory
Topics Artificial Intelligence
Q4 Testing & Diagnostics Services Earnings: RadNet (NASDAQ:RDNT) Impresses
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how testing & diagnostics services stocks fared in Q4, starting... 
Via StockStory
Analyst Scoreboard: 4 Ratings For RadNet
 
Via Benzinga
P/E Ratio Insights for RadNet
 
Via Benzinga
What 5 Analyst Ratings Have To Say About RadNet
 
Via Benzinga
Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking Quest (NYSE:DGX)
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Quest (NYSE:DGX) and the best and worst... 
Via StockStory
Top 3 Health Care Stocks You'll Regret Missing This Quarter
 
Via Benzinga
RadNet’s (NASDAQ:RDNT) Q4 Sales Top Estimates But Stock Drops
Diagnostic imaging company RadNet (NASDAQ:RDNT) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 13.5% year on year to $477.1 million. On the other hand, the... 
Via StockStory
Topics Artificial Intelligence
Unveiling 7 Analyst Insights On RadNet
 
Via Benzinga
Peeling Back The Layers: Exploring RadNet Through Analyst Insights
 
Via Benzinga
Cracking The Code: Understanding Analyst Reviews For RadNet
 
Via Benzinga
What To Expect From RadNet’s (RDNT) Q4 Earnings
Diagnostic imaging company RadNet (NASDAQ:RDNT) will be reporting results tomorrow after market hours. Here’s what to look for. 
Via StockStory
Jim Cramer: This Industrial Stock Is 'Absolutely Terrific', First Solar Is 'Very Inexpensive'
First Solar will report financial results for the fourth quarter and full year ended Dec. 31, 2024, after the closing bell on Tuesday, Feb. 25, 2025. 
Via Benzinga
Top 3 Health Care Stocks That Could Blast Off This Quarter
 
Via Benzinga
DaVita Stock Sees Improved Relative Strength Rating
DaVita stock saw a welcome improvement to its Relative Strength (RS) Rating on Friday, with an upgrade from 64 to 72. 
Via Investor's Business Daily
The Next Wave of Health AI: Analysts Highlight Breakthroughs in Clinical Trials and Patient Care
USA News Group Commentary Issued on behalf of Avant Technologies Inc. Vancouver, BC – December 17, 2024 – USA News Group News Commentary – Artificial intelligence (AI) is on the brink of becoming a... 
Via FinancialNewsMedia
Topics Artificial Intelligence
How AI is Shaping the Future of Healthcare: Key Advances in Diagnostics and Precision Medicine
EQNX::TICKER_START (OTCQB:AVAI),(NYSE:BFLY),(NASDAQ:TEM),(NASDAQ:GEHC),(NASDAQ:RDNT) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
MARA Holdings, RadNet, Bit Digital, Coinbase And Other Big Stocks Moving Higher On Monday
 
Via Benzinga
GE HealthCare And DeepHealth Team Up To Advance AI-Powered Breast Cancer Screening: Details
GE HealthCare and DeepHealth collaborate to develop AI-powered solutions for imaging, starting with breast cancer screening. 
Via Benzinga
Imaging Centers Operator RadNet Q3 Earnings: Strong Q3 Performance On Positive Trends, Raises Annual Outlook
RadNet posted Q3 2024 revenue of $461.1 million, beating estimates. Digital Health revenue rose 34.3%, driving growth in AI mammography. 
Via Benzinga
Topics Artificial Intelligence
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.